These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Duvelisib for the treatment of chronic lymphocytic leukemia. Frustaci AM; Tedeschi A; Deodato M; Zamprogna G; Cairoli R; Montillo M Expert Opin Pharmacother; 2020 Aug; 21(11):1299-1309. PubMed ID: 32292084 [TBL] [Abstract][Full Text] [Related]
4. Duvelisib for CLL/SLL and follicular non-Hodgkin lymphoma. Patel K; Danilov AV; Pagel JM Blood; 2019 Nov; 134(19):1573-1577. PubMed ID: 31554637 [TBL] [Abstract][Full Text] [Related]
5. Transient hypophysitis in a patient treated by duvelisib for chronic lymphocytic leukemia. Orioli L; Sarti K; Van Den Neste E; Maiter D Ann Hematol; 2017 Apr; 96(4):685-686. PubMed ID: 28150013 [No Abstract] [Full Text] [Related]
6. Idelalisib for chronic lymphocytic leukemia. Brown JR Clin Adv Hematol Oncol; 2014 Dec; 12(12):846-8. PubMed ID: 25674842 [No Abstract] [Full Text] [Related]
7. Management of advanced chronic lymphocytic leukemia. Cao TM; Coutre SE Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156 [TBL] [Abstract][Full Text] [Related]
8. [New European approval: Duvelisib - relapsed/refractory CLL and follicular lymphoma]. Fornero L; Lamure S Bull Cancer; 2021 Oct; 108(10):906-907. PubMed ID: 34607678 [No Abstract] [Full Text] [Related]
9. Promising results Halt phase III studies of idelalisib. Inman S Am J Manag Care; 2014 Feb; 20(2 Spec No.):E9. PubMed ID: 25764575 [No Abstract] [Full Text] [Related]
10. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies. Robak T Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872 [TBL] [Abstract][Full Text] [Related]